-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, I36SqnvioGcwnmpoBuC6BLlRA461SUevDoitqmLndJs+h77hKf3SJzR5/9f8VSoU 9lzMdqOSoUofoh07st+P8Q== 0000893838-05-000125.txt : 20050517 0000893838-05-000125.hdr.sgml : 20050517 20050517213037 ACCESSION NUMBER: 0000893838-05-000125 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050513 FILED AS OF DATE: 20050517 DATE AS OF CHANGE: 20050517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Park Young Soon CENTRAL INDEX KEY: 0001316422 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50590 FILM NUMBER: 05840135 BUSINESS ADDRESS: BUSINESS PHONE: (240) 268-5300 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REXAHN PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001228627 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113516358 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9620 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 2402685300 MAIL ADDRESS: STREET 1: 9620 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: CORPORATE ROAD SHOW DOT COM INC DATE OF NAME CHANGE: 20030423 3 1 rexahnfrm3yspark051605_ex.xml X0202 3 2005-05-13 0 0001228627 REXAHN PHARMACEUTICALS, INC. RXHN 0001316422 Park Young Soon 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 1 0 1 0 Common Stock 2909000 D Common Stock 166000 I Held through Korean Rexahn Investors Voting Trust Ted T.H. Jeong is signing on behalf of Young Soon Park pursuant to a power of attorney filed as an Exhibit hereto. /s/ Ted T.H. Jeong as attorney-in-fact for Young-Soon Park 2005-05-17 EX-24 2 poapark.txt POWER OF ATTORNEY The undersigned, as a Section 16 and Section 13(d) reporting person of Rexahn Pharmaceuticals, Inc. (the "Company"), hereby constitutes and appoints each of Ted T.H. Jeong, Chang H. Ahn and Inok Ahn the undersigned's true and lawful attorneys-in-fact to: 1. Complete and execute forms and schedules and all amendments thereto as such attorneys-in-fact shall in their discretion determine to be required or advisable pursuant to Sections 16 and 13(d) of the Securities Exchange Act of 1934 (as amended) and the rules and regulations promulgated thereunder, or any successor laws and regulations, as a consequence of the undersigned's ownership, acquisition or disposition of securities of the Company; and 2. Do all acts necessary in order to file such forms and schedules with the Securities and Exchange Commission, any securities exchange or national association, the Company and such other person or agency as the attorneys-in-fact shall deem appropriate. The undersigned hereby ratifies and confirms all that said attorneys-in-fact and agent shall do or cause to be done by virtue hereof. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Sections 16 and 13(d) of the Securities Exchange Act of 1934 (as amended). This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file forms and schedules with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Company and the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 16th day of May, 2005. Signature Date --------- ---- /s/ Young Soon Park May 16, 2005 - ------------------------------ Name: Young Soon Park -----END PRIVACY-ENHANCED MESSAGE-----